Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Cancer Monthly is reporting on a published study that appears to be more bad news for the manufacturers of the once-popular diabetes drug, Actos. The drug, also known as pioglitazone, was designed to help with glycemic control, but multiple studies have shown a connection between Actos and bladder cancer.
In a report in Tumour Biology, scientists at the Wu Qing District People’s Hospital in Tianjin, China detailed the results of their meta-analysis of 9 available studies on diabetics and Actos. Together, the studies included more than 2.5 million diabetic patients and the researchers say the results were clear: “The result suggested an increased risk of bladder cancer in patients exposed to pioglitazone (Actos),” they write.
http://www.digitaljournal.com/pr/1779994
In a report in Tumour Biology, scientists at the Wu Qing District People’s Hospital in Tianjin, China detailed the results of their meta-analysis of 9 available studies on diabetics and Actos. Together, the studies included more than 2.5 million diabetic patients and the researchers say the results were clear: “The result suggested an increased risk of bladder cancer in patients exposed to pioglitazone (Actos),” they write.
http://www.digitaljournal.com/pr/1779994